diarrhea with retatrutide Unapproved weight loss drug causes extreme side effects Retatrutide (“reta”) is an experimental
Description
We also evaluated acute treatment with tirzepatide, a dual GLP-1/gastric inhibitory peptide (GIP) receptor agonist, and retatrutide, a triple GIP/GLP-1/glucagon receptor agonist, to determine whether broader receptor activity would differentially influence alcohols subjective effects
J Biol Chem 261:1188011889
FDA Concerns Surrounding Compounded GLP-1 In a May 16, 2025 statement, the U.S
overnight emergency rescue 2
Wegovy (semaglutide) is registered for weight management in the USA
However, it usually takes 3-6 months to experience the full benefits
